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Abstract
Background
In patients with end stage kidney disease (ESKD) on dialysis, treatment non-adherence is
common and results in poor health outcomes. However, the clinical benefits of interventions
to improve adherence in dialysis patients are difficult to evaluate since trialled interventions
and reported outcomes are highly diverse/ heterogeneous. This review summarizes existing
literature on randomized controlled trials (RCTs) evaluating adherence interventions in
ESKD patients focusing on the intervention category, outcome efficacy and persistence of
benefit beyond the intervention.
Methods
We performed electronic database searches in Medline, Embase & Cochrane CENTRAL
upto 1st July 2018 for RCTs evaluating interventions to improve diet, fluid, medication or dial-
ysis adherence in ESKD patients. Study characteristics including category of interventions,
outcomes, efficacy and follow-up were assessed. Meta-analysis was used to compute
pooled estimates of the effects on the commonest reported outcome measures.
Results
From 1311 citations, we included 36 RCTs (13 cluster-randomized trials), recruiting a total
of 3510 dialysis patients (mean age 55.1 ± 5.8 years, males 58.1%). Overall risk of bias was
‘high’ for 24 and of ‘some concern’ for 12 studies. Most interventions (33 trials, 92%)
addressed patient related factors, and included educational/cognitive (N = 11), behavioural /
counselling (N = 4), psychological/affective (N = 4) interventions or a combination (N = 14)
of the above. A majority of (28/36) RCTs showed improvement in some reported outcomes.
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Surrogate measures like changes in phosphate (N = 19) and inter-dialytic weight gain (N =
15) were the most common reported outcomes and both showed significant improvement in
the meta-analysis. Sixteen trials reported follow-up (1–12 months) beyond intervention and
the benefits waned or were absent in nine trials within 12 months post-intervention.
Conclusions
Interventions to improve treatment adherence result in modest short-term benefits in surro-
gate outcome measures in dialysis patients, but significant improvements in trial design and
outcome reporting are warranted to identify strategies that would achieve meaningful and
sustainable clinical benefits.
Limitations
Poor methodological quality of trials. Frequent use of surrogate outcomes measures. Low
certainly of evidence.
Introduction
Adherence to therapy, which is also known as treatment compliance, denotes the extent to
which a person’s behaviour of taking medication, following a diet, and / or executing lifestyle
changes, corresponds with the recommendations from a health care provider [1]. Poor adher-
ence to treatment or treatment non-adherence is associated with worse health outcomes, in
terms of increased mortality and morbidity [2]. However, non-adherence is common in
patients with chronic diseases and patients with end stage kidney disease (ESKD) who are on
dialysis are no exception [1]. Non-adherence may be intentional or un-intentional and several
patient-related, disease-related, and treatment-related factors can contribute to non-adherence
in dialysis patients [3].
Studies evaluating interventions to improve treatment adherence in dialysis patients have
broadly addressed four domains of therapy; namely, adherence to recommendations regarding
diet, fluid intake, dialysis treatment and medications [4, 5]. The lack of standardized methods
to measure adherence in these domains, contributes to the reported variations in the rate of
non-adherence, and the difficulty of precisely estimating the effectiveness of interventions to
improve adherence [3, 5]. Methods of measuring adherence vary across studies and include
indirect measures, such as self-reported adherence [6, 7]; direct measures such as pill counts or
electronic medication event monitoring system (MEMS) [8], and attendance in dialysis ses-
sions [9]; as well as surrogate measures such as inter-dialytic weight gain [10, 11] or biochemi-
cal parameters, which include phosphate and potassium levels [12, 13].
The interventions to help improve adherence in dialysis patients have also varied between
studies. A systematic review of RCTs to improve adherence to dialysis, medication, diet and
fluid intake in haemodialysis patients published in 2010, concluded that cognitive behavioural
interventions offered the best promise for future studies [4]. A subsequent review by the same
authors [5] and more recent systematic reviews focusing on specific outcome like inter-dialytic
weight gain and phosphate control have included both randomized and non-randomized
intervention studies [14, 15]. Non-randomized trials make up the majority of adherence inter-
vention studies in dialysis patients [5], but the lack of random allocation of participants makes
them susceptible to selection bias. Several pertinent randomized trials of adherence
strategies to improve treatment adherence in dialysis patients: A systematic review of randomzied trials
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interventions have been published in the last decade, indicating a keen interest in this research
area. In this context, we undertook a systematic review of RCTs in patients with ESKD under-
going dialysis (population), evaluating the effect of interventions to improve dietary, fluid,
dialysis or medication adherence (intervention) compared to usual care or alternative strate-
gies (control) on direct, indirect or surrogate measures (outcome) of adherence. Our objectives
were to categorize various adherence interventions, examine whether the reported adherence
outcomes are clinically meaningful, identify which interventions are effective in improving
clinical outcomes and evaluate whether the benefits persist beyond the trialled interventions.
Materials and methods
This systematic review, was structured on the Preferred Reporting Items for Systematic
Reviews and Meta-Analyses (PRISMA) statement and check-list [16]. We included random-
ized trials published as full-text articles in the English language, which evaluated interventions
to improve adherence to fluid, diet, medication or dialysis, or a combination of these domains,
in ESKD patients undergoing dialysis. The review was registered at PROSPERO, the interna-
tional prospective register of systematic reviews in February 2018 (http://www.crd.york.ac.uk/
PROSPERO/display_record.php?ID=CRD42018087899)
Search strategy
Electronic database searches were performed via OvidSP in the Medline, Embase and
Cochrane central register of controlled trials for relevant articles using standard search strate-
gies. Medical subject headings or search terms included combinations of ‘dialysis’, ‘renal dialy-
sis’, ‘hemodialysis’, ‘peritoneal dialysis’, ‘patient compliance’, ‘adherence’, ‘medication
adherence’, and text word searches using combinations of ‘adheren�’, ‘non-adheren�’ ‘non-
adheren�’, ‘complian�’, ‘non-complian�’, ‘noncomplian�’, ‘fluid’, ‘diet’, ‘diet�’, ‘medication’,
‘dialys�’, inter-dialy�’, interdialy�’, ‘haemodialys�’, hemodialys�’, ‘peritoneal dialys�’, and
‘CAPD’ were conducted with searches restricted to ‘English’ and ‘humans’. An example search
strategy used for Medline is provided as S1 Table. Search results in the form of titles and
abstracts were analyzed by three authors (KM, HH, KL), to identify the studies to be included
in the final review, based on the criteria outlined below. Any disagreement was resolved by dis-
cussion among all authors. In addition, references in the included articles and other important
reviews on the topic were hand-searched to identify articles that might have been missed in
the previous searches.
Study selection criteria
Studies that evaluated adult ESKD patients undergoing haemodialysis or peritoneal dialysis
were considered. Trials using random allocation of participants to different groups using a
parallel group, cluster randomization or randomized crossover design were eligible for inclu-
sion. Studies were included if they trialled at least one intervention, aimed at improving at
least one measure of adherence pertaining to one or more domains of ESKD treatment adher-
ence; namely, dietary, fluid, dialysis or medication adherence, as a pre-specified primary or
secondary outcome. The reported measure of adherence outcome could have included indirect
(e.g. self-reported adherence) or direct (e.g. MEMS-Medication event monitoring system), as
well as surrogate measures, which included biochemical parameters (e.g. phosphate level) or
inter-dialytic weight gain. For inclusion, studies needed to report the adherence measure
before and after the intervention or the change in the adherence measure in response to the
intervention. Non-randomized intervention trials and observational studies were excluded as
strategies to improve treatment adherence in dialysis patients: A systematic review of randomzied trials
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were non-primary research articles (letters to the editor, brief communications and review
articles).
Data extraction and synthesis
A standard check-list developed by the authors was used to extract the following data from the
included studies: the year of publication, journal, first author’s name, funding source, study
design, number of participants in the intervention and control arms, study population charac-
teristics, trialed intervention and control treatments, theoretical model of behaviour underpin-
ning the intervention (if any), primary and secondary outcomes, measures of adherence
before and after the intervention or the change in the adherence measures as a result of the
intervention, whether adherence was directly measured during the conduct of the study, dura-
tion of follow-up, dropout rate, significant secondary outcomes and whether the benefits of
intervention persisted on follow-up. If the intervention resulted in significant improvement in
the pre-specified direct or indirect adherence efficacy measures (excluding knowledge), the
study outcome was considered positive. However, if there was no significant improvement, the
study was considered negative, or if there was improvement in some but not all of the pre-
specified outcome measures, the study was considered partially positive. One author (KM)
extracted the above information into the datasheet, and two authors (HH, KL) verified the
accuracy.
A synthesis of the extracted data was then undertaken to group the various interventions
under the broad categories of adherence interventions for chronic diseases proposed by the
World Health Organization (WHO) [1], listed as (a) Social and economic interventions, (b)
Health system / healthcare team related interventions, (c) Therapy related, (d) Condition or
disease related and (e) Patient related interventions.
The patient level interventions were further sub-grouped into the categories of adherence
interventions proposed by De Bleser et al [17]
1. Educational/cognitive interventions which provide information or knowledge about disease
or treatment to the patient
2. Counselling/ behavioural interventions which addressed patient’s behaviour or skill rele-
vant to self-care or empowered them to participate in their care
3. Psychologic/affective interventions that appealed to the patient’s feelings and emotions or
social support and
4. Mixed interventions that involved a combination of the above-mentioned intervention
types.
We also undertook meta-analysis to compute a pooled estimate of effect for the most com-
monly reported outcomes in the included trials.
Quality of included studies
We assessed the risk of bias for the main outcome for each study, rather than applying a ‘qual-
ity scale’ to evaluate the methodological quality of the included trials. We opted against the
‘quality scales’ because they tend to combine and assign similar weighting to aspects of study
conduct and quality of reporting, which is difficult to justify [18]. In this review we used the
Cochrane risk of bias tool version 2.0 (ROB 2.0) for randomized trials [19] to assess study qual-
ity. Two authors (HH and KL) independently assessed the risk of bias for the five domains of
potential bias using the ROB tool. The results were compared to reach a consensus on the risk
of bias estimates by consultation and the remaining differences were resolved in discussion
strategies to improve treatment adherence in dialysis patients: A systematic review of randomzied trials
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with the first author (KM). The overall risk of bias was assessed for each study in a similar
fashion.
Statistical methods
Continuous variables were expressed as means ± standard deviation and proportions were
expressed as percentages. We compared proportions using Fisher’s exact test. Inter-rater reli-
ability of the risk of bias domains was assessed using Cohen’s kappa statistics. In the meta-
analysis, we used the mean difference in the adherence outcome between intervention and
control arms as the effect measure, and the random effect option as the analysis model. When
the standard deviation of the mean difference was not directly available for use in the meta-
analysis from the publication, we contacted the authors seeking this information. However, if
it was still unavailable, we computed standard deviation from the confidence intervals or p val-
ues cited in the paper, using t-statistics [20]. In situations where these metrics were not cited in
the paper, we imputed the standard deviation from the arithmetic mean [20] of the standard
deviations of the mean difference in the intervention and control arms respectively. Publica-
tion bias was evaluated using funnel plots along with the meta-analysis, which was conducted
using Review manager software Version 5.3 (Copenhagen: The Nordic Cochrane Centre, The
Cochrane Collaboration, 2014). Egger’s test was used to detect the skewness of the funnel plot
and objectively assess the publication bias [21]. The statistical analyses were conducted using
Stata version 15.1.
Quality of evidence and ‘Summary of findings’ table
The quality of evidence in this systematic review was rated using the GRADE (Grade of Recom-
mendation, Assessment, Development and Evaluation) approach, which takes into account vari-
ous factors that can reduce the quality of evidence, such as within-trial risk of bias, inconsistency
of results, indirectness of evidence, imprecision and publication bias, as well as factors that
improve the quality like large magnitude of effect and dose-response gradient [22]. We used
GRADEpro software to create a summary of findings table for the main outcomes, which pro-
vides an overall rating for each outcome and the explanations for grading the evidence [23].
Results
Search results
Electronic searches in Medline, Embase and Cochrane central register of controlled trials were
completed on 1st July 2018 to identify relevant articles published till that date using search
strategies described above. The searches did not limit the range of publication years. The
broad electronic database search retrieved 1311 citations out of which 78 adherence interven-
tion trials in dialysis patients were identified, based on the criteria outlined above. Seven trials,
which were missed in the database search, were identified by hand search of references from
important systematic reviews relevant to the topic. Out of these 85 studies, thirty-six random-
ized trials which fulfilled the specified inclusion and exclusion criteria were identified for
inclusion in the review (for details, please refer to Fig 1).
Study characteristics
Out of the 36 studies included in the review, 22 had a parallel group design, while one trial [10]
adopted a randomized crossover design. The remaining studies were cluster randomized trials
(for details please refer to Table 1).
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The total number of participants in the included studies was 3510, with 1729 in the inter-
vention and 1781 in the control arms. The number of participants in the different trials ranged
from 15 to 394 [32, 35] with a median of 70 patients. Three trials recruited patients undergoing
peritoneal dialysis [26, 32, 50] while the remaining 33 studies recruited haemodialysis patients.
The mean age was 55.1years (standard deviation (SD) 5.8years) and male patients constituted
a majority (mean 58.1%, SD 12.2%) of the study participants.
Four studies [8, 11, 24, 51] indicated that they were partly or fully supported by pharmaceu-
tical sponsors, whereas 20 studies were funded by public organisations, including universities.
No information on funding source was provided in twelve studies.
Risk of bias
Assessment of included studies using the Cochrane ROB 2.0 tool [19] with respect to the five
domains of potential risk of bias, showed a high inter-rater agreement of 76.7% (between
authors HH and KL) based on independently abstracted data (Kappa 0.58, p<0.001), which
was further strengthened (inter-rater agreement 95.6%, Kappa 0.92, p<0.001) after consulta-
tion. The remaining differences were resolved by discussion between authors. The overall risk
of bias in the included trials was judged as ‘high risk’ for 24 studies and ‘some concern’ for the
remaining 12 studies. With respect to four out of the five individual risk domains, a majority
of the studies were judged to be of ‘some concern’ or ‘high risk’ (for details refer to Fig 2).
With respect to the ‘risk of bias in measurement of the outcome’, even though blinding of the
outcome assessment was not implemented or specified in most of the studies, more than half
of the included trials were assessed as ‘low risk’. This was because, the main efficacy measures
Fig 1. Flow chart of study selection in the systematic review.
https://doi.org/10.1371/journal.pone.0211479.g001
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Table 1. Characteristics of the trials included in the review.
Reference Trial design /
Population (Type of
adherence) /
Interventionist
(theoretical models of
behaviour if any)
Total No
(Intervention/
Control) N/ Mean
age (years)
Intervention Domain and (category)
of adherence
intervention / Duration
of intervention
(d = day, wk = weeks,
m = months)
Outcome relevant to
treatment adherence
Total F/U in m
(months) / Study
result / Benefit
sust-ained
beyond
intervention
Ashurst I de
Brito et al
(2003) [24]
Parallel group / HD
(Diet + Medication)
/Dietitian
58 (29/29) / 53.6 One-on-one education session
by Dietitian based on "A
Patient’s guide to keeping
healthy: Managing your
phosphate", manual developed
by Genzyme Pharmaceuticals.
Also provided Medication chart
to fill in self-administered doses
of medications and blood
results to increase patient
engagement
Patient related
interventions
(Educational/cognitive)
/ 1 d
Change in levels of
phosphate, calcium,
calcium x phosphate
product
6 m/ Partially
positive
Baraz S et al
(2010) [13]
Parallel group / HD
(Diet+ Fluid
+ Medication) /
Nurses
63 (31/32) / 34.9 Oral education lasting 30
minutes each over two group
sessions and a booklet "A
patient’s guide to controlling
dietary regimen" vs Video
education lasting 30 minutes
during haemodialysis session
with similar content including
diet, importance of compliance
etc
Patient related
interventions
(Educational/
cognitive) / 1 d
Change in IDWG.
Change in levels of
phosphate, calcium,
potassium
4 m / Partially
positive
Brantley P J
et al (1990)
[25]
Cluster randomized /
HD (Vascular access
cleansing) / Multiple
staff
56 (14/14#/ 14#/
14) / 56.6
Educational video of vascular
access cleansing lasting
20minutes for 3 sessions over
one week (Educational) /
provision of visual cues to help
cleaning, such as information
board and monetary incentives
in the form of raffles
(Behavioural)/, the above two
together (Educational &
Behavioural) / attention control
included video about vascular
access without information on
cleaning ((Control)
Patient related
interventions
(Educational/ cognitive
& Counselling /
behavioural) / 1 wk
Vascular access cleansing
compliance
12 m / Positive at
1 month / Benefit
wanes @ 12 m F/
U
Chen W et al
(2006) [26]
Parallel group / PD
(Diet) / Dietitian
70 (35/35) / 55.3 Food menu suggestion and
individualized education on
food exchange based on patient
preference
Patient related
interventions
(Educational/cognitive)
/ 1 d
Protein intake
compliance computed
from 3 days self-reported
diet, Change in levels of
phosphate, albumin
1 m / Partially
positive
Cho M K
et al (2013)
[12]
Parallel group / HD
(Diet + Fluid
+ Medication) /
Nurses (King’s theory
of goal attainment)
43 (21/22) / 60.4 Health contract intervention
lasting 30–60 minutes per week
for 4 weeks which included
formal introduction to the
program, mutual goal setting,
contracting and re-contracting
to support selfcare behaviour
reinforced through praise,
encouragement and support
Patient related
interventions
(Counselling /
behavioural) / 4 wk
Inventory (develop-ed by
Song et al) to assess self-
care behaviour including
fluid intake, diet,
medications, exe-rcise,
physical man-agement
and social adjustment,
Change in IDWG,
Change in levels of
phosphate, potassium
1 m / Partially
positive/ NA
(Continued)
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Table 1. (Continued)
Reference Trial design /
Population (Type of
adherence) /
Interventionist
(theoretical models of
behaviour if any)
Total No
(Intervention/
Control) N/ Mean
age (years)
Intervention Domain and (category)
of adherence
intervention / Duration
of intervention
(d = day, wk = weeks,
m = months)
Outcome relevant to
treatment adherence
Total F/U in m
(months) / Study
result / Benefit
sust-ained
beyond
intervention
Cukor D
et al (2014)
[10]
Crossover randomized
/ HD (Fluid) /
Psychologist
59 (33/26) Cognitive behavioural therapy
(CBT) delivered chairside by
psychologist over 60 minutes
per for 3 months. Included
psycho-education emphasising
difference between depression
and medical illness,
components of adherence
targeting dialysis compliance,
adapting behavioural activation
and identifying ESRD specific
cognitive distortions
Patient related
interventions
(Educational/ cognitive
& Counselling /
behavioural) / 3 m
Change in IDWG 6 m / Partially
positive / Positive
@ 3 m/ Benefit
wanes @ 3 m F/U
Cummings
K M et al
(1981) [27]
Parallel group / HD
(Diet + Fluid) / Nurses
(Health belief model)
96 (24/19#/ 28#/
25) / 54.8
Three Intervention groups. 1.
Behavioural contracting
(included Identifying behaviour
needing change, set time table
for change, writing formal
agreement and recording of
progress) with reward schedule
in the form of lottery tickets 2.
Above intervention with family
member/friend in addition to
patient 3. Weekly telephone
contact by nurse with
structured content including
identification of non-
adherence, highlighting
information on negative
consequences of non-adherence
and verbal support for
maintaining adherence once a
week for 6 weeks with hope of
modifying health beliefs
Patient related
interventions
(Counselling /
behavioural) / 6 wk
Change in IDWG.
Change in levels of
potassium, Health beliefs
about diet and fluid
4.5 m / Partially
positive / Positive
@ 6 wk/ No
benefit @ 3m F/U
de Araujo L
P et al (2010)
[28]
Parallel group / HD
(Diet + Medication) /
Multiple staff
33 (16/17) / 52.5 Six educational sessions lasting
30 minutes each about
importance of avoiding high
phosphate diet, correct use of
phosphate binders, importance
of blood results of calcium,
phosphate, calcium, phosphate
product, PTH and
manifestations of bone disease
in a course over 2 weeks
Patient related
interventions
(Educational/cognitive)
/ 2 wk
Change in levels of
phosphate, calcium,
calcium x phosphate
product, PTH,
Knowledge about diet
and binders
3 m / Negative
(only one
outcome
assessment @ 3
m)
Ford J C et al
(2004) [29]
Parallel group / HD
(Diet + Medication) /
Dietitian
70 (35/35) 20–30 minutes of additional
dietary education every month
by dietician in addition to
standard education, using tools
including posters, handouts,
puzzles, individual
phosphorous tracking
instruments highlighting
dietary phosphate content,
importance of diet, drugs and
dialysis in phosphate control
Patient related
interventions
(Educational/cognitive)
/ 6 m
Change in levels of
phosphate, calcium,
calcium x phosphate
product, PTH,
Knowledge about diet
and binders
6 m / Partially
positive / NA
(Continued)
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Table 1. (Continued)
Reference Trial design /
Population (Type of
adherence) /
Interventionist
(theoretical models of
behaviour if any)
Total No
(Intervention/
Control) N/ Mean
age (years)
Intervention Domain and (category)
of adherence
intervention / Duration
of intervention
(d = day, wk = weeks,
m = months)
Outcome relevant to
treatment adherence
Total F/U in m
(months) / Study
result / Benefit
sust-ained
beyond
intervention
Forni Ogna
V et al
(2013) [8]
Parallel group / HD
(Medication) /
Multiple staff
50 (24/26) / 60.2 Integrated care approach
(MEMS monitoring,
motivational interviewing start
2m later with MEMS graphical
report, identify barriers to non-
adherence and strategies to
address them, discussion about
adherence)
Patient related
interventions
(Educational/cognitive
& Counselling /
behavioural) / 6 m
Change in levels of iPTH
level, MEMS adherence
(cinacalcet taking) and
dose of Cinacalcet
9 m / Positive @ 6
m/ Benefit wanes
@ 3 m post
intervention
Griva K et al
(2018) [30]
Cluster randomized /
HD (Diet + Fluid
+ Med + Dialysis) /
Multiple staff (Social
cognitive theory)
235 (101/134) /
53.5
Three core and one booster
group education sessions,
totalling 8 hours, targeting self-
management behaviour related
to fluid intake, diet and
medications and telephone
follow-up between core &
booster sessions
Patient related
interventions
(Educational/ cognitive
& Counselling /
behavioural) / 3 m
(including core &
booster sessions &
phone F/U)
Change in IDWG.
Change in levels of
phosphate, potassium.
Renal adherence behav-
iour questionnaire (Fluid,
potassium, phosphate,
sodium, adherence in
times of difficulty, self-
care)
9 m / Positive @
3m/ Benefit
wanes @ 9 m post
intervention
Haq N et al
(2014) [31]
Parallel group / HD
(Medication) / Dialysis
staff
23 (12/11) / 52.5 Directly observed therapy in
front of haemodialysis nurses
administering cinacalcet 3
times a week during dialysis
Health system related
interventions
(Supervised therapy) / 4
m
Change in levels of
phosphate, calcium, PTH
4 m / Negative /
NA
Hare J et al
(2014) [32]
Parallel group / PD
(Fluid) / Psychologist
(Health belief model)
15 (8/7) / 60.1 Group format CBT for groups
of 6–8 patients at a time in
1-hour sessions per week for 4
weeks. The program was called
Liquid intake program (LIP)
which was adapted (and
renamed) from the Glasgow
university liquid program
(GULP) used in by Sharp et al
2005. The structured program
included Introduction, goal
setting and environment
change, thought, emotions and
behaviour as well as social
support and program review
Patient related
interventions
(Educational/ cognitive
& Counselling
/behavioural) / 4 wk
Fluid adherence assessed
by weight reduction
>2Kg, BP, Psychological
markers (psychological
well-being, quality of life,
health beliefs)
2.5 m / Negative
post-intervention
& 6 wk F/U
Hou Y M
et al (2010)
[33]
Parallel group / HD
(Fluid) / Psychologist
(ABC theory)
92 (48/44) / 44.6 Rational emotive therapy
establishing a good patient-
caregiver relationship with a
structured program with
introduction providing basic
knowledge and psychological
health, description of rational
emotive therapy and ABC
theory, procedure of rational
emotive therapy in three phases
including psycho-diagnosis,
comprehension and application
Patient related
interventions
(Psychological /
affective) / 3 m
Change in IDWG, BP,
Ultrafiltration volume
3 m /Positive /
NA
(Continued)
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Table 1. (Continued)
Reference Trial design /
Population (Type of
adherence) /
Interventionist
(theoretical models of
behaviour if any)
Total No
(Intervention/
Control) N/ Mean
age (years)
Intervention Domain and (category)
of adherence
intervention / Duration
of intervention
(d = day, wk = weeks,
m = months)
Outcome relevant to
treatment adherence
Total F/U in m
(months) / Study
result / Benefit
sust-ained
beyond
intervention
Howren M B
et al (2016)
[34]
Cluster randomized /
HD (Fluid) /
Psychologist (Self-
regulation theory)
119 (61/58) /57.1 Highly structured behavioural
self-regulation intervention
sessi-ons administered by
psychologists to group of 3–8
participants lasting one hour
weekly for 7 weeks, including
illustration of behavioural
principles, group discussions
and homework assign-ments
specific to fluid adherence
comprising of self-regulation
techniques, goal setting, self-
administered reinforcement
strategies, stimulus control,
evaluation of group experience
Patient related
interventions
(Counselling
/behavioural &
Psychological /
affective) / 7 wk
Change in IDWG 8 m / Positive /
Benefit present @
6 m F/U
Karavetian
M et al
(2013) [7]
Cluster randomized /
HD (Diet
+ Medication) /
Dietitian (Self efficacy
theory)
122 (41/41 #/40) /
57.0
Self-management dietary
counselling and interactive
games for 20 minutes per week
for 8 weeks. Also included
discussion for 10 minutes every
month about bone mineral
disease related parameters and
relevant nutritional counselling
Patient related
interventions
(Educational/ cognitive
& Counselling /
behavioural) / 8wk
Change in levels of
phosphate, calcium,
calcium x phosphate
product. Knowledge.
Dietary non-adherence
by questionnaire
2 m / Positive /
NA
Karavetian
M et al
(2015) [35]
Cluster randomized /
HD (Diet) / Dietitian
(Trans-theoretical
model)
394 (88/ 201#
/96)/ 58.8
Individualized intensive trans-
theoretical stage-based
nutrition education twice
weekly for six months by an
academic dietitian. A partial
intervention group provided a
second control group
Patient related
interventions
(Educational/cognitive)
/ 6 m
Change in phosphate
levels. Phosphate intake.
Knowledge about dietary
phosphate
12 m / Positive at
6 month / Benefit
wanes @ 6 m F/U
Kauric-Klein
Z et al (2012)
[9]
Cluster randomized /
HD (Diet + Fluid
+ Medication
+ Dialysis) / Nurses
118 (59/59) / 59.7 Two blood pressure education
sessions, self-monitoring of BP
for 12 weeks checking it twice a
day with logs, goal setting for
BP levels, Fluid gains and Salt
intake and haemodialysis
compliance with reinforcement
sessions lasting 10–15 minutes
per week for twelve weeks with
supportive nursing intervention
Patient related
interventions
(Educational/ cognitive
& Counselling /
behavioural) / 12wk
BP self-care beh-aviour,
(IDWG, Salt intake, BP
med adherence–self-re-
ported), BP, Dialysis
adherence (missed HD
sessions)
4 m /Partially
positive @ 3m /
Benefit persists @
1 m F/U
Lou LM et al
(2012) [36]
Cluster randomized /
HD (Diet) / Dietitian
80 (41/39) / 62.3 Register with dietitian who
provides detailed menu
suggestions adapted to patients
plus targeted dietary education
concerning phosphorous intake
lasting 30minutes every by
dietitian
Patient related
interventions
(Educational/cognitive)
/ 6 m
Change in levels of
phosphate. Per-centage of
patients achieving phos-
phate goal. PTH.
Nutritional measur-es—
BMI/ albumin/ fat free
mass
6 m / Positive /
NA
(Continued)
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Table 1. (Continued)
Reference Trial design /
Population (Type of
adherence) /
Interventionist
(theoretical models of
behaviour if any)
Total No
(Intervention/
Control) N/ Mean
age (years)
Intervention Domain and (category)
of adherence
intervention / Duration
of intervention
(d = day, wk = weeks,
m = months)
Outcome relevant to
treatment adherence
Total F/U in m
(months) / Study
result / Benefit
sust-ained
beyond
intervention
Molaison E F
et al (2003)
[37]
Cluster randomized /
HD (Fluid) / Multiple
staff (Trans-theoretical
model)
316 (216/100) /
53.8
Dietitian intervention using
stages of change in the trans-
theoretical model to improve
fluid intake. First 6 weeks phase
of Pre-action including
precontemplation and
contemplation, second 6week
phase of Action including
preparation, action and
maintenance. Communication
to patients maintained through
bulletin boards, handouts and
feedback. Constructs included
consciousness raising, self-
evaluation, counter-
conditioning, stimulus control,
self-efficacy etc
Patient related
interventions
(Educational/ cognitive
& Counselling /
behavioural) / 12wk
Change in IDWG, Stage
of change in fluid
adherence, Knowledge
3 m / Negative
/Knowledge
improved / NA
Morey B et al
(2008) [38]
Parallel group / HD
(Diet + Medication) /
Dietitian
67 (34/33) / 57.7 Intensive dietary counselling
every month for 6months about
phosphate in diet and
phosphate binder use using
motivational counselling,
behaviour modification
therapy, reminders,
reinforcement, supportive care
as well as written and verbal
education
Patient related
interventions
(Educational/ cognitive
& Counselling
/behavioural) / 6 m
Change in levels of
phosphate, calcium,
calcium x phosph-ate
product, PTH, albumin,
Nutritional measures:
hand grip, mid-arm
circumference
12 m / Negative
after intervention
@ 6 m & 6 m F/U
Neumann C
L et al (2013)
[11]
Parallel group / HD
(Fluid) / Multiple staff
120 (60/60) / 66.1 Body weight telemetry with
phone calls triggered by
thresholds detected during
monitoring with >1.5kg/d
weight gain mandating phone
call, 0.75–1.5Kg/d weight gain
prompting individualized
decision making based on
patient profile
Health system related
interventions
(Monitoring /
engagement) / 3 m
Change in IDWG, BP 3 m / Partially
positive / NA
Pasyar N
et al (2015)
[39]
Parallel group / HD
(Diet + Fluid
+ Medication) /
Professional relaxation
therapist
86 (43/43) Benson relaxation technique of
progressive muscle relaxation
with breathing awareness for 20
minutes twice a day for 8 weeks
Patient related
interventions
(Psychological /
affective) / 8 wk
Change in IDWG,
Change in levels of
phosphate, potassium,
chemistry
2 m / Partially
positive / NA
(Continued)
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Table 1. (Continued)
Reference Trial design /
Population (Type of
adherence) /
Interventionist
(theoretical models of
behaviour if any)
Total No
(Intervention/
Control) N/ Mean
age (years)
Intervention Domain and (category)
of adherence
intervention / Duration
of intervention
(d = day, wk = weeks,
m = months)
Outcome relevant to
treatment adherence
Total F/U in m
(months) / Study
result / Benefit
sust-ained
beyond
intervention
Reese P P
et al (2015)
[6]
Parallel group / HD
(Diet + Medication) /
Dietitian
36 (12/12#/ 12) /
53.0
Intervention group 1 received
financial incentives including
envelopes with cash and lottery
for achieving goal range and
those with above goal range
received envelopes with
messages designed to avoid
regret aversion. Intervention
group 2 received coaching for
45–60 minutes 3 times a week
by Dietitian trained in
motivational interviewing,
structured as per Precaution
Adoption process model in
addition to discussing
phosphate in diet, phosphate
binders and identified
personalized goals to achieve
dietary and medication
adherence
Patient related
interventions
(Educational/ cognitive
& Counselling /
behavioural) / 10 wk
Change in level of
phosphate, Medication
adherence by
questionnaire
2.5 m / Negative /
NA
Sehgal A R
et al (2002)
[40]
Cluster randomized /
HD (Dialysis) /
Multiple staff
169 (85/84) / 54.5 Identify barriers with respect to
low prescription, catheter use
for access and shortened
treatment time & individually
address by liaising with
randomized nephrologists and
engaging with patients to
resolve barriers
Health system related
interventions / Patient
related interventions
(Monitoring / engage-
ment & Educational /
cognitive) / 6m
Change in Kt/V,
Proportion of patients
achieving goal Kt/V
6 m / Positive /
NA
Sharp J et al
(2005) [41]
Cluster randomized /
HD (Fluid) /
Psychologist (Health
belief model)
56 (29/27) / 54.3 Glasgow University liquid
intake program (GULP)
administered by Psychologist
structured as small group (3–8
subjects) interactive sessions
lasting 1 hour per week for 4
weeks, with educational
component providing
information about importance
of fluid restriction, behavioural
component of teaching self-
monitoring skills, goal setting
and self-regulation as well as
cognitive components of
encouraging to identify
association between thoughts,
emotions and behaviours.
Patients were advised to
complete thought records
Patient related
interventions
(Educational/ cognitive
& Counselling /
behavioural) / 4 wk
Change in IDWG,
Health-belief
Questionnaire adapted
from Friend et al
regarding fluid
3.5 m / Negative
@ 4 weeks /
Benefit within
group @ 10 wk F/
U
Shi Y X et al
(2013) [42]
Parallel group / HD
(Diet + Medication) /
Nurses
80 (40/40) / 53.3 Nurse led education lasting 30
minutes two or three times a
week for six months, written
educational material and
monthly group educational
sessions for six months
Patient related
interventions
(Educational/cognitive)
/ 6 m
Change in levels of
phosphate, calcium,
calcium x phosphat- e
product, albumin,
Knowledge
6 m / Positive /
NA
(Continued)
strategies to improve treatment adherence in dialysis patients: A systematic review of randomzied trials
PLOS ONE | https://doi.org/10.1371/journal.pone.0211479 January 29, 2019 12 / 27
Table 1. (Continued)
Reference Trial design /
Population (Type of
adherence) /
Interventionist
(theoretical models of
behaviour if any)
Total No
(Intervention/
Control) N/ Mean
age (years)
Intervention Domain and (category)
of adherence
intervention / Duration
of intervention
(d = day, wk = weeks,
m = months)
Outcome relevant to
treatment adherence
Total F/U in m
(months) / Study
result / Benefit
sust-ained
beyond
intervention
Skoutakis V
A et al (1978)
[43]
Parallel group / HD
(Diet + Medication) /
Pharmacist
24 (12/12) / 47.0 Pharmacist review two to three
times a week for four months
supplying educational
materials, consultation
regarding health, benefits of
compliance with diet and
medicines and written
reminders about taking oral
medications. Clarification of
physician instructions and drug
titration advice was also
provided
Patient related
interventions
(Educational/
cognitive) / 4 m
Knowledge, Weighted
drug dose compliance
(differ-ent drug classes).
Weighted biochem-ical
profile (potassium, urea,
Weight gain, BP)
8 m / Positive /
Benefit wanes @ 4
m F/U
Sullivan C
et al (2009)
[44]
Parallel group /
Cluster randomized /
HD (Diet) / Dietitian
279 (145/134) /
53.0
Education about phosphorous
content of food additives,
provision of magnifier lens to
enable food label readings,
printed information containing
fast food info and better
choices. Telephone contact next
month to reinforce advice
Patient related
interventions
(Educational/
cognitive) / 2 m
(including telephone F/
U)
Change in level of
phosphate, Nutritional
knowledge, Reading
labels
3 m / Partially
positive / NA
Tanner JL
et al (1998)
[45]
Parallel group / HD
(Diet + Fluid
+ Medication) /
Dietitian (Health
belief model / Self
efficacy theory)
40 (30/10) / 50.2 Monthly progress report with
IDWG (<3Kg weekdays, <4Kg
weekends), and phosphorous
(<5.9mg/dl) goals with sticker
incentives for acceptable results
and monthly written
behavioural contracts to assist
in one or more goals. Results
reviewed monthly and
recontracted each month,
increasing complexity over time
Patient related
interventions
(Counselling /
behavioural) / 6 m
Change in level of
phosphate, Number of
dialysis sessions with
acceptable IDWG (>8 of
12 HD sessions), Knowle-
dge, Self-efficacy
6m / Negative
(Knowledge was
better @ 6 m) /
NA
Tsay S L et al
(2003) [46]
Parallel group / HD
(Fluid) / Nurses (Self
efficacy theory)
62 (31/31) / 57.7 Structured self-efficacy training
comprising of a total of 12
sessions of one hour each,
individualized education about
renal failure, haemodialysis,
medications, fluid restrictions
performance mastery, realistic
gaol setting, verbal persuasion
with encouragement and
decreased arousal through
physical relaxation listening to
audiotapes. Patients also were
advised to maintain food and
fluid records
Patient related
interventions
(Educational /cognitive
& Counselling
/behavioural) / 1 m
Change in IDWG 6m / Positive /
Benefits present
@ 6m
Welch J L
et al (2013)
[47]
Parallel group / HD
(Fluid + Overall) /
Nurses (Social
cognitive theory)
44 (24/20) / 50.3 Dietary intake monitoring
application (DIMA) a mobile
application developed using
nutrition database and
universal product code (UPC)
database, provides
individualized ongoing
information to assist patients
with dietary and fluid self-
monitoring
Patient related
interventions
(Educational/cognitive
& Counselling
/behavioural) / 6 wk
Change in IDWG, Self-
efficacy measures by
modified Cardiac diet
self-efficacy (SE)
instrument & Fluid SE
scale
14 wk / Negative /
NA
(Continued)
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Table 1. (Continued)
Reference Trial design /
Population (Type of
adherence) /
Interventionist
(theoretical models of
behaviour if any)
Total No
(Intervention/
Control) N/ Mean
age (years)
Intervention Domain and (category)
of adherence
intervention / Duration
of intervention
(d = day, wk = weeks,
m = months)
Outcome relevant to
treatment adherence
Total F/U in m
(months) / Study
result / Benefit
sust-ained
beyond
intervention
Wileman V
et al (2016)
[48]
Cluster randomized /
HD (Fluid) /
Psychologist (self-
affirmation theory)
89 (49/40) / 60.7 Re-affirmation act before
receiving health information
about fluid overload and risks
at baseline and briefer re-
affirmation act before health
information at 1,3 and 6
months. The act required
participants to recall past act of
kindness. The health
information was followed by
questionnaire exploring
perception of risk, intention
and self-efficacy to control their
fluid intake.
Patient related
interventions
(Psychological /
affective) / 6m
(including F/U sessions
@ 3m & 6m)
Change in IDWG. Self-
reported measure of fluid
intake (1–5 scale), Self-
efficacy
12 m / Partially
positive / Benefits
persisted @ 12 m
Wileman V
et al (2014)
[49]
Cluster randomized /
HD (Diet
+ Medication) /
Psychologist (self-
affirmation theory)
112 (57/55) / 60.5 Re-affirmation act before
receiving health information
about phosphate control and
risks at baseline and briefer re-
affirm-ation act before health
information at 1,3 and 6
months. The act required
participants to recall past act of
kindness. The health
information was followed by
questionnaire exploring
perception of risk, intention
and self-efficacy to control their
phosphate.
Patient related
interventions
(Psychological /
affective) / 1 d
Change in phosphate
levels, Self-reported
measures, Self-efficacy
12 m / Partially
positive / Benefits
persisted @ 12 m
Wong F K Y
et al (2010)
[50]
Parallel group / PD
(Diet + Fluid
+ Medication
+ Dialysis) / Nurses
98 (49/49) / 62.4 Nurse led disease management
program for 6 wk based on the
4-Cs model comprising of
Comprehensiveness,
Collaboration, Coordination
and Continuity-run by Renal &
General nurses. Content of the
program included assessment
using the Omaha system
modified for renal patients, arts
and skills of telephone nursing,
setting mutual goals and health
coaching, use of disease
management protocols and
concept of disease management
process and outcomes
Health system related
interventions
(Monitoring /
engagement) / 6 wk
Self-reported adherence
using a modified version
of dialysis, diet and fluid
questionnaire (DDFQ)
3 m / Partially
positive / Some
benefits persist @
3m
Yokum D
et al (20018)
[51]
Parallel group / HD
(Diet + Medications) /
Multiple staff
34 (17/17) / 49.4 Pharmacist & Dietitian adjust
phosphate binders as per
protocol in addition to monthly
reviews by Pharmacist and
Dietitian to provide education
and reinforcement
Health system related
interventions / Patient
related interventions
(Monitoring /
engagement &
Educational / cognitive)
Change in phosphate,
calcium, calcium x
phosphate product, PTH
4 m / Partially
positive / NA
Abbreviations or symbols used in the table: BP = blood pressure, CBT = cognitive behavioural therapy, ‘d’ = day, F/U = follow-up, HD = haemodialysis, IDWG = inter-
dialytic weight gain, ‘m’ = months, MEMS = medication event monitoring system, NA = not applicable, PD = peritoneal dialysis, PTH parathyroid hormone, ‘wk’ =
weeks,
# indicates the number of patients in alternative intervention group. Additional details about the study characteristics and outcome data are provided in S2 Table.
https://doi.org/10.1371/journal.pone.0211479.t001
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in these trials were biochemical measurements or changes in body weight, which may not be
impacted by the lack of blinding of the outcome assessor. It should be appreciated that these
surrogate adherence outcomes are susceptible to measurement error, depending on the test
conditions. Changes in the timing of blood sampling in relation to dialysis, length of inter-dia-
lytic interval, or variations in clothing worn by the subject can lead to biased measurement of
phosphate levels or body weight. However, such variations will not be modified by outcome
assessor blinding and have not been factored into the risk of bias estimates in this review.
Additional details of the risk of bias assessment of individual studies are provided in S3 Table.
Interventions
When the article did not describe which aspect of ESKD treatment adherence, -i.e. dietary,
fluid-related, dialysis related or medication adherence, was addressed in the study, it was
inferred from the nature of the trialled interventions or the reported outcome. For example,
reporting of inter-dialytic weight gain as an outcome was interpreted as evaluating adherence
to fluid recommendations, while changes in phosphate level as an outcome were interpreted as
testing adherence to dietary and medication recommendations. It is acknowledged that these
assumptions may not be valid under all circumstances and could lead to misclassification in
some cases. Fluid adherence was assessed in nine studies, medication adherence tested in two
studies [8, 31], while four studies [26, 35, 36, 44] assessed dietary adherence, and one study
each evaluated dialysis adherence [40] and vascular access cleansing [25]. The remaining nine-
teen studies evaluated various combinations of dietary, medication, dialysis and fluid adher-
ence (refer to Table 1).
The evaluated intervention was delivered by a variety of health care professionals in the dif-
ferent studies, with dietitians (10 trials) and nurses (9 trials) being the most frequent. Psycholo-
gists were the interventionists in seven trials, while a pharmacist [43] and relaxation therapy
Fig 2. Risk of bias assessment of the included studies. The data presented for individual risk of bias domains are based on Cochrane ROB 2.0 tool [19] for
randomized trials.
https://doi.org/10.1371/journal.pone.0211479.g002
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professional [39] delivered the intervention in one study each. The remaining eight studies
had multiple staff involved or provided no specific information on the interventionist.
In fifteen studies (42%), theoretical models of behaviour relevant to treatment adherence
formed the basis of the trialled intervention. The health belief model [27, 32, 41, 45] was the
most commonly used, while self-efficacy theory [7, 45, 46], social cognitive theory [30, 47],
self-affirmation theory [48, 49], trans-theoretical models (TTM) [35, 37], self-regulation theory
[34], King’s theory of goal attainment [12] and the ABC (Antecedents, Behaviour, Conse-
quences) model relevant to rational emotive therapy [33] were also invoked. Six out of seven
studies, where the interventionist was a psychologist, had a theoretical behavioural
underpinning.
Taking into account the five categories of adherence interventions outlined in the WHO
report [1], 33 studies (92%) addressed patient related factors. Health system or health care
team related interventions were tested in five studies [11, 31, 40, 50, 51], two of which [40, 51]
also addressed patient related factors. Interventions addressing social-economic factors, ther-
apy related factors or disease or condition related factors were not tested in any of the trials
(Refer to Table 1).
When we assigned the patient related interventions into the subcategories proposed by De
Bleser et al [17], several studies appeared to align with more than one subcategory. The domi-
nant category was assigned by consensus, with guidance when necessary from the senior psy-
chologist among the authors. Eleven studies evaluated educational or cognitive interventions,
four had behavioural or counselling interventions [6, 12, 27, 45], four had psychological or
affective interventions [33, 39, 48, 49] and fourteen studies had elements of different categories
in the trialled intervention (refer to Table 1).
Controls
Twenty six of the 36 randomized trials (72%) assigned control patients to usual or standard
care, including standard health or nutritional education. Wait-listed controls were employed
in three studies [10, 32, 41], while the remaining studies used some type of intervention as a
comparator to match the active intervention. The comparator included attention control [25],
placebo support and discussion control conditions [34], provision of matching health informa-
tion without prior reaffirmation activity [48, 49], use of a daily activity monitoring application
[47], and health education which was different from the trialled intervention [13, 28]. Four
studies [7, 25, 27, 35] included in this review also had two or more active (partial or alternative)
intervention arms in addition to the main intervention and control arms (refer to Table 1).
Outcome assessment
The reported outcome data which reflected treatment adherence were diverse and mostly
included surrogate measures (refer to Table 1). For the only crossover study [10] in our review,
we included the data for the initial phase of randomized comparison between the intervention
and control arms, before the crossover. Inter-dialytic weight gain or change in weight or pro-
portion of sessions with satisfactory weight gain was reported as a fluid adherence outcome in
18 studies, while blood pressure (BP) control was assessed in four studies. Biochemical param-
eters were reported as an adherence outcome in 23 studies, which included combinations of
blood levels or change in levels of phosphate (n = 19), calcium (n = 10), calcium phosphate
product (n = 7), PTH (n = 7), potassium (n = 5) or albumin (n = 3). Dialysis adherence data,
identified as missed or shortened dialysis sessions or changes in biochemical parameters (pre-
dialysis BUN, Kt/V), was provided in three studies[30, 40, 43]. Dietary adherence information
was provided in two studies [9, 26]. Indirect estimates of adherence, as self-reported or
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otherwise, were given in seven studies, while direct measures of medication adherence using
an electronic medication event monitoring system (MEMS) was reported in only one study
[8]. Assessment of knowledge or beliefs about disease or therapy, including medications, or
self-efficacy was reported in six studies (refer to Table 1).
Outcome efficacy
The trialled intervention was effective in improving the adherence outcome measures in twelve
studies, while in sixteen studies the intervention led to mixed results, with improvement in
some pre-specified outcome measures but failing to show significant benefit in other adher-
ence outcomes (refer to Table 1). For example, in twelve trials which reported two or more
biochemical markers as surrogate outcome measures in response to adherence interventions,
eight showed improvement in phosphate levels, but five of these studies [13, 24, 29, 39, 51]
showed no significant improvement in other surrogate adherence outcomes such as calcium x
phosphate product, PTH or potassium. The evaluated intervention, did not result in an
improvement in any of the adherence outcome measures in eight trials, although two of these
studies [37, 45] showed improvement in the participant’s knowledge and awareness about the
relevant issues, as a result of the intervention (refer to Table 1). The outcome efficacy, whether
positive or negative, was not significantly associated with the type of interventionist (dietitian
or nurses or others) (p = 0.929, Fisher’s exact test), the category of intervention (educational/
cognitive or others) (p = 0.388, Fisher’s exact test) or the use of a theoretical model of behav-
iour (p = 0.694, Fisher’s exact test) in planning the intervention.
Meta-analysis
We computed pooled estimates of the mean differences in phosphate levels and inter-dialytic
weight gain in response to the adherence intervention between active and control groups.
Though these are only surrogate outcome measures and susceptible to confounding, we chose
them for meta-analysis because these were the most commonly reported efficacy measures in
the included trials. As shown in Figs 3 and 4, both phosphate levels and inter-dialytic weight
gain significantly improved in response to the adherence intervention, and the level of statisti-
cal heterogeneity was moderate (I2 of 47% and 37% respectively) for the two analyses. As
shown in Figs 5 and 6, the funnel plots did not show significant publication bias in the analysis
of nineteen studies reporting a change in phosphate levels (Egger’s test p = 0.901, intercept 0.1,
slope -0.33) or fifteen studies reporting a change in inter-dialytic weight gain (Egger’s test
p = 0.224, intercept -1.3, slope 0.04) as the adherence outcome. Please refer to S1 and S2 Figs.
Duration of intervention and follow-up
The median duration of total follow-up of all the included studies was 129 days, with a mini-
mum of 4 weeks to a maximum of 12 months. The intervention could be as brief as a single
educational session lasting less than an hour [13, 24] but more typically involved several struc-
tured sessions over many weeks. Educational, behavioural and psychological interventions
were nearly always conducted on dialysis days in patients on haemodialysis. The duration of
follow-up after completion of the intervention varied from 0 days (where the intervention con-
tinued until the final outcome assessment) to one year with a median of 42 days. For details of
the duration of intervention and total follow-up of individual studies, please refer to Table 1.
Information on persistence of efficacy of intervention beyond the first outcome assessment
was not provided in 20 (56%) studies. Among the remaining 16 studies, the benefits of the
trialled intervention had waned or was not detectable by six weeks in one study [32] three
months in four studies [8, 10, 27, 43], six months in two studies [35, 38] and by nine months
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[30] and twelve months [25] in one study each. The impact of the adherence intervention on
the outcomes persisted for twelve months after the intervention in two trials [48, 49], for six
months in two trials [34, 46], for three months in two trials [41, 50] and for one month in one
trial [9]. For details of the persistence or decline of efficacy of intervention during follow-up of
the individual trials, please refer to Table 1.
Fig 3. Forest plot showing the change in phosphate in response to adherence interventions. The mean difference is measured in mg/dL (to convert mg/dL to
mmol/L, multiply by 0.323).
https://doi.org/10.1371/journal.pone.0211479.g003
Fig 4. Forest plot showing the change in inter-dialytic weight gain in response to adherence interventions. The mean difference is measured in Kg of body weight.
https://doi.org/10.1371/journal.pone.0211479.g004
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Quality of evidence
Confidence in the evidence presented in this review, rated using the GRADE approach was
‘very low’ for the two most commonly reported outcomes. With respect to the factors affecting
Fig 5. Funnel plot evaluating publication bias for studies that reported a change in phosphate level as an
adherence outcome.
https://doi.org/10.1371/journal.pone.0211479.g005
Fig 6. Funnel plot evaluating publication bias for studies that reported a change in inter-dialytic weight gain as an
adherence outcome.
https://doi.org/10.1371/journal.pone.0211479.g006
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quality of evidence, we rated down the quality by one level for the domains of risk of bias,
inconsistency and imprecision, while we rated down the quality by two levels for indirectness.
Publication bias was not detected and did not contribute to the very low certainty of evidence.
The summary of findings for these comparisons is given below in Table 2.
Discussion
Our systematic review of randomized intervention trials to improve treatment adherence in
dialysis patients shows a moderate, but often partial and short-lasting improvement in pre-
specified adherence outcomes. The review also demonstrates a narrow focus on strategies
addressing patient related factors, with shortfalls in study design and implementation, some of
which are inherent to the non-discrete and heterogeneous nature of adherence behaviour.
Comprehensive adherence interventions should target the patient, the provider and the
health care system and address social-economic factors, therapy related, patient related, disease
related and health system related factors [1]. More than 90% of the trials included in our
review addressed patient related factors contributing to non-adherence. In dialysis patients,
several factors such as access to care, complexity of the treatment regimens, heavy pill burden,
lower socio-economic status, poor health literacy and associated comorbidities, such as depres-
sion and cognitive impairment, can predispose to non-adherence [52]. However health care
providers often erroneously assume that the patients should be motivated to adhere to the best
practice treatment protocol [1], which might explain why the vast majority of trials have
addressed patient related factors. It is important to recognize that the health behaviour of
Table 2. Interventions to improve treatment adherence compared to usual care or alternative interventions for improving surrogate adherence outcomes in dialysis
patients.
Patient or population: haemodialysis or peritoneal dialysis
Setting: dialysis units or outpatients
Intervention: Interventions to improve treatment adherence
Comparison: usual care or alternative interventions
Outcomes No of
participants
(studies)
Certainty of
the evidence
(GRADE)
Anticipated absolute effects
Risk with usual care or alternative
interventions
Risk difference with Interventions to improve
treatment adherence
Change in inter-dialytic
weight gain
1539
(15 RCTs)
⨁◯◯◯
VERY LOW
a,b,c,d
The mean change in inter-dialysis weight gain
was 0.15 to -0.9 Kg
MD 0.2 lower
(0.32 lower to 0.08 lower)
Change in serum
phosphorous
1631
(19 RCTs)
⨁◯◯◯
VERY LOW
a,b,c,d
The mean change in serum phosphate was 0.59
to -1.09 mg/dL
MD 0.45 lower
(0.66 lower to 0.23 lower)
�The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention
(and its 95% CI).
CI: Confidence interval; MD: Mean difference
GRADE Working Group grades of evidence
⨁⨁⨁⨁ High certainty: We are very confident that the true effect lies close to that of the estimate of the effect
⨁⨁⨁◯ Moderate certainty: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a
possibility that it is substantially different
⨁⨁◯◯ Low certainty: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect
⨁◯◯◯ Very low certainty: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect
Explanations
a. Majority comparisons were unblinded, not analysed as intention to treat and inadequately reported important confounders and outcomes
b. Moderate heterogeneity across studies, which is not directly explained by variations in study characteristics
c. Interventions were highly diverse, used surrogate outcome measures and most trials did not undertake direct measurement of adherence
d. Optimal information size criteria unlikely to be met since the clinical importance of the pooled estimate of mean difference is doubtful
https://doi.org/10.1371/journal.pone.0211479.t002
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treatment adherence, is the product of diverse but overlapping variables, and comprehensive
strategies addressing different issues are required to achieve sustained improvement in
adherence.
Change in behaviour such as adherence is a very complex process, parts of which have been
conceptualized in various theoretical models of behaviour in over 40% of the included trials.
Not surprisingly, trials implemented by psychologists were more likely to invoke such theoreti-
cal frameworks including ‘social cognitive theory’, ‘stages of change or trans-theoretical
model’, health belief model’ and ‘goal setting theory’. The integrated model of behaviour
change or I-change model, which loosely assimilates the above theories and the ‘theory of
planned behaviour’, assumes three phases in the process of change, namely awareness, motiva-
tion and action [53]. Information or knowledge about the various aspects of therapy is essen-
tial to build awareness, but information by itself is not sufficient to achieve or sustain
behaviour change [1]. Educational or cognitive interventions constituted the sole trialled regi-
men in one third of the studies in this review, while they were part of the components of the
interventions in the majority of studies. Improved knowledge as a result of educational inter-
ventions did not translate to a sustained improvement in the measure of adherence, at least in
some studies [37, 45], confirming that behaviour change requires more than the acquisition of
new knowledge.
Many of the RCTs in our review have evaluated varying combinations of educational-cog-
nitive, behavioural-counselling and psychological-affective interventions, with significant
overlap between categories. Cognitive behaviour therapy (CBT) refers to a set of intervention
strategies aimed at assisting patients in identifying and altering their own dysfunctional cogni-
tions like unhelpful thoughts, beliefs and attitudes, thereby improving their mental well-being
and coping behaviour [41]. In contrast to some short-sighted behavioural modification tech-
niques, a change in belief might enable patients to internalize the cognitive rationale for alter-
ing their behaviour [27]. CBT is a focused psychotherapy aimed at changing the way the
individual thinks, feels and behaves, and, unlike traditional psychotherapy it is practical and
action-oriented [10]. The systematic review on interventions to improve adherence in dialysis
patients by Matteson et al, [4] concluded that cognitive behavioural interventions offered the
best promise for future trials. In our review, the category of intervention, whether cognitive or
behavioural or affective, was not significantly associated with the efficacy of outcome, but the
overlap between categories may have affected the reliability of our analysis.
A major issue noted in this review was the frequent use of surrogate outcome measures of
adherence. Biochemical and physiological measurements such as phosphate, albumin, Kt/V
and inter-dialytic weight gain have been widely used as measures of adherence in dialysis
patients [4, 54]. Some of these measures can be modified by factors other than adherence, like
residual renal function and quality of dialysis [5]. For example, phosphate levels, which may
reflect dietary non-adherence or non-adherence to phosphate binding medications may be
affected by inadequate dialysis due to suboptimal vascular access. Marked variations in dialytic
phosphate clearance, inconsistency in dietary phosphate absorption, and up to two-fold varia-
tions in the efficacy of phosphate binders between individuals, may account for the hyperpho-
sphataemia in dialysis patients, rather than non-adherence to diet and medication [55].
Similarly, inter-dialytic weight gain may be unreliable as a measure of fluid non-adherence in
patients with significant residual urine volume. Failure to address these confounders can lead
to misclassification of adherence, and biased efficacy estimates. In this review, self-reported
measures of adherence, which are well known to overestimate adherence [5] were used in one
in five studies. However, direct measurement of adherence using ‘pill count’ or the electronic
medication event monitoring system (MEMS) which are more robust methods to assess medi-
cation adherence [1], was used in only one out of 36 included trials.
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The reporting of a large number of heterogeneous outcomes, many of which are not neces-
sarily patient centred, is not confined to adherence intervention trials but is common in the
broader nephrology literature. Initiatives are already underway to identify and implement a set
of core outcomes for all trials in haemodialysis (SONG-HD) [56] and peritoneal dialysis
(SONG-PD) [57] patients, based on the shared priorities of all stakeholders. The widespread
adoption of standardized outcome reporting in the future will facilitate meaningful compari-
sons and pooling of results of dialysis patient trials, including studies evaluating treatment
adherence.
A large proportion of the interventions evaluating patient related factors in this review
resulted in significant improvement in some of the pre-specified measures of adherence while
not impacting on other measures. Since the adherence interventions were not specific for one
type of measure over the other, the observed benefits should be interpreted with caution. It is
always possible that despite the interventions being outcome non-specific, some of the out-
come measures, owing to their biological characteristics, may be more amenable to manipula-
tion than others. We should also remember that when multiple comparisons are made
between a study factor and several outcome factors, some of them may return a significant
effect due to chance alone.
In a chronic disease like ESKD, it would be reasonable to assume that persistent long-term
adherence to therapy would be required to achieve sustained clinical benefits. In our review,
the follow-up period for the adherence interventions was relatively short, ranging from four
weeks to 12 months. It is conceivable that in patients with ESKD, trials with such short follow-
up periods are unlikely to identify any meaningful clinical benefits, other than surrogate mark-
ers of adherence which demonstrate a proof of concept about the efficacy of adherence
interventions.
Even when a behavioural change in response to an adherence intervention is adopted,
relapse of the original behaviour of non-adherence can occur and relapse prevention is an
important strategy in achieving long-term adherence [37]. With brief interventions and short
duration of follow-up, there is less opportunity for behavioural reinforcement, with a higher
attendant risk of relapse of non-adherence. The majority of the studies (55%) in our review
did not report whether adherence persisted beyond the first outcome assessment. In the six-
teen studies that provided this information the beneficial effect of adherence intervention
waned or was not detectable by 12 months or less in nine studies, while a persistent benefit at
12 months was reported in only two studies. These observations also highlight the importance
of having a longer duration of adherence interventions, with appropriate reinforcement strate-
gies, and longer periods of follow-up, to help demonstrate the sustained benefit from such
interventions.
Our review has several strengths. It summarizes the research that addresses an important
aspect of dialysis patient care, which has the potential to improve patient outcomes. The broad
criteria for including trials in this review helped us to cover all important domains of dialysis
patient therapy. This has also helped us to identify a significant number of studies including
those used in the meta-analysis. Presenting the breadth of categories of adherence interven-
tions and outcomes, in both haemodialysis and peritoneal dialysis patients, based on up to
date medical literature, is the main contribution of the current review to the existing research
in this field.
However, this review has several limitations. Many of the included trials were small in size,
took place in diverse clinical settings and were not of a high methodological quality. The inter-
ventions were not homogeneous in nature or intensity. There was a lack of consistency in out-
come reporting and follow-up between studies. This made it difficult to effectively compare
the interventions or recommend specific strategies to improve treatment adherence in this
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vulnerable population. The widespread use of surrogate adherence efficacy measures, with the
potential for residual confounding, and the relatively short duration of follow-up, made it diffi-
cult to judge the true extent of sustainable benefit from these interventions. It is noteworthy
that only 8% of the included trials recruited patients on peritoneal dialysis, which could limit
the applicability of our review to this population. We included studies which were published as
full text articles in English language only and may have missed important trials published in
non-English languages. Including such trials may have improved the quality of our review, but
this was out of the scope of resources available for this project.
The quality of evidence in this review was rated as ‘very low’ using the GRADE approach.
This would imply that the true effect may be substantially different from the effect estimate
detected in our review and future high-quality studies may provide different results. The
insights from conducting this review enable us to propose, what such a high-quality adherence
intervention trial should aim to achieve. The interventions should be well defined and translat-
able to routine clinical practice. The outcomes should be clinically meaningful, and the study
design should specifically address factors other than adherence which can confound the evalu-
ated outcome measures, especially when surrogate measures of adherence efficacy are used.
Direct measurement of adherence should be undertaken whenever feasible. The intervention
should be of sufficient duration with a plan for periodic reinforcement, which is essential for
sustained behaviour change. The follow-up should extend beyond intervention to assess its
residual effect and identify the risk of relapse of non-adherence. With an increased interest in
the topic in recent years, it is realistic to anticipate that such robust trials will emerge and the
results from such trials will enable us to identify effective adherence interventions that would
become part of routine clinical care in the future.
Conclusions
In this systematic review we have identified that interventions to improve treatment adherence
in dialysis patients are effective in improving surrogate efficacy outcomes, at least in the short
term. However, there is considerable scope for improvement in the design and conduct of adher-
ence intervention trials to evaluate whether specific strategies can lead to reliable and lasting ben-
efits with respect to meaningful clinical outcomes in patients with ESKD who are on dialysis.
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